Global Emphysema Treatment Market to reach USD 12.12 billion by 2027.

Global Emphysema Treatment Market Size Study with Covid-19 Impact, by Type (Centrilobular emphysema and Panlobular emphysema), By Application (Hospital, Clinics, Surgical Centre) and Regional Forecasts 2020-2027
Product Code:  HALDAT_79041570
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Emphysema Treatment Market, by Region, 2018-2027 (USD Billion)
1.2.2.	Emphysema Treatment Market, by Type, 2018-2027 (USD Billion)
1.2.3.	Emphysema Treatment Market, by Application, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Emphysema Treatment Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Emphysema Treatment Market Dynamics	
3.1.	Emphysema Treatment Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Emphysema Treatment Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Emphysema Treatment Market, by Type 
5.1.	Market Snapshot 
5.2.	Global Emphysema Treatment Market by Type, Performance - Potential Analysis
5.3.	Global Emphysema Treatment Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4.	Emphysema Treatment Market, Sub Segment Analysis
5.4.1.	  Centrilobular emphysema 
5.4.2.	Panlobular emphysema
Chapter 6.	Global Emphysema Treatment Market, by Application 
6.1.	Market Snapshot 
6.2.	Global Emphysema Treatment Market by Application, Performance - Potential Analysis
6.3.	Global Emphysema Treatment Market Estimates & Forecasts by  Application 2017-2027 (USD Billion)
6.4.	Emphysema Treatment Market, Sub Segment Analysis
6.4.1.	 Hospital 
6.4.2.	Clinics 
6.4.3.	Surgical Centre	 
Chapter 7.	Global Emphysema Treatment Market, Regional Analysis
7.1.	Emphysema Treatment Market, Regional Market Snapshot 
7.2.	North America Emphysema Treatment Market 
7.2.1.	U.S. Emphysema Treatment Market	 Type breakdown estimates & forecasts, 2017-2027	 Application breakdown estimates & forecasts, 2017-2027 
7.2.2.	Canada Emphysema Treatment Market
7.3.	Europe Emphysema Treatment Market Snapshot
7.3.1.	U.K. Emphysema Treatment Market 
7.3.2.	Germany Emphysema Treatment Market
7.3.3.	France Emphysema Treatment Market
7.3.4.	Spain Emphysema Treatment Market
7.3.5.	Italy Emphysema Treatment Market
7.3.6.	Rest of Europe Emphysema Treatment Market
7.4.	Asia-Pacific Emphysema Treatment Market Snapshot
7.4.1.	China Emphysema Treatment Market 
7.4.2.	India Emphysema Treatment Market 
7.4.3.	Japan Emphysema Treatment Market
7.4.4.	Australia Emphysema Treatment Market
7.4.5.	South Korea Emphysema Treatment Market
7.4.6.	Rest of Asia Pacific Emphysema Treatment Market
7.5.	Latin America Emphysema Treatment Market Snapshot
7.5.1.	Brazil Emphysema Treatment Market
7.5.2.	Mexico Emphysema Treatment Market
7.6.	Rest of The World Emphysema Treatment Market

Chapter 8.	Competitive Intelligence
8.1.	Top Market Strategies
8.2.	Company Profiles
8.2.1.	  Pulmonx	Key Information	Overview	Financial (Subject to Data Availability)	Product Summary	Recent Developments
8.2.2.	  Teva Pharmaceutical Industries Ltd.
8.2.3.	Cipla Limited
8.2.4.	Pfizer Inc.
8.2.5.	Olympus Corporation
8.2.6.	Mariposa Health
8.2.7.	 PneumRx  
8.2.8.	Uptake Medical
8.2.9.	BTG plc  
8.2.10.	Kamada
8.2.11.	GlaxoSmithKline (GSK)  
8.2.12.	Icure Pharmaceutical    
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.2.	Research Attributes
9.3.	Research Assumption

Global Emphysema Treatment Market is valued approximately USD 7.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6.61 % over the forecast period 2020-2027. Emphysema is a long -term, progressive lung disease and it is also considered to be a form of chronic obstructive pulmonary diseases. Also, it primarily affects the alveolar walls & upper lobes of lungs. Emphysema is of two type centrilobular emphysema and panlobular emphysema. The centrilobular emphysema begins in the respiratory bronchioles and spread peripherally. This is also associated with the long-standing cigarette smoking and predominantly involves the upper half of the lungs. As per the NCBI, centrilobular emphysema is the commonest type of pulmonary emphysema and is closely related with cigarette smoking. Moreover, the growth of the market is attributed owing to the high prevalence in COPD (Chronic Obstructive Pulmonary Disease), an inflammatory lung disease which includes emphysema. For Instance: as per the Chest Foundation Organization in 2020, in America, approximately 12 million Americans live with chronic obstructive pulmonary disease and around 24 million individuals live with undiagnosed chronic obstructive pulmonary disease. As a result, the reduce the prevalence of the centrilobular emphysema, the demand for the emphysema treatment such as medication, antibiotics & bronchodilators would increase as these treatments would help to relieve some symptoms and also help individual to breath better. However, adverse health effects impede the growth of the market over the forecast period. Furthermore, growing smoking habit of population would also create lucrative growth aspects for the growth of the market during the forecast period of 2020-2027. Additionally, the pandemic has significantly affected all aspects of life, including the people with severe COPD as they have high risk of Covid-19 complications since it affects the respiratory systems. As a response, there is a tremendous rise in demand of the emphysema treatments across the globe.

The regional analysis of global Emphysema Treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increase in proportion of urban population, changing lifestyle, growing number of tobacco smokers and rising pollution levels. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Teva Pharmaceutical Industries Ltd.
Cipla Limited
Pfizer Inc.
Olympus Corporation
Mariposa Health
Uptake Medical
BTG plc
GlaxoSmithKline (GSK)
Icure Pharmaceutical

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Centrilobular emphysema
Panlobular emphysema
By Application:
Surgical Centre
By Region:
North America

Asia Pacific
South Korea
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Emphysema Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.